Covered recipient · General Payments record

CAVATINA L PHAM

Allopathic & Osteopathic Physicians Family Medicine

NPI: 1821409780
CMS profile: 1385612
Location: HOUSTON, TX

General Payments · PY2018–2024

$10,041.84

Reported across 646 records
CMS publication 2026-01-23

Latest program year · PY2024

$1,333.38

72 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$1,333.38	72

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
Novo Nordisk AS	$210.93	14
Bayer HealthCare Pharmaceuticals Inc.	$154.86	9
Boehringer Ingelheim Pharmaceuticals, Inc.	$151.38	11
BOSTON SCIENTIFIC CORPORATION	$141.64	2
DEXCOM, INC.	$109.26	4
Sumitomo Pharma America, Inc.	$86.30	4
Lilly USA, LLC	$80.42	4
GlaxoSmithKline, LLC.	$76.33	4
PFIZER INC.	$67.60	4
Acerta Pharma LLC	$63.20	4
Amgen Inc.	$48.57	3
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$43.40	3
Exact Sciences Corporation	$31.24	2
OptiNose US, Inc.	$20.02	1
Seqirus USA Inc	$19.86	1
Merck Sharp & Dohme Corporation	$14.75	1
Currax Pharmaceuticals LLC	$13.62	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$952.52	56
PY2019	$1,302.93	84
PY2020	$1,438.18	91
PY2021	$1,936.20	107
PY2022	$1,658.57	112
PY2023	$1,420.06	124
PY2024	$1,333.38	72

Payment records · PY2024 (72)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
Amgen Inc.	$18.95	02/20/2024	Food and Beverage	Undisputed	01/23/2026	1111676209	CMS
Amgen Inc.	$14.53	03/25/2024	Food and Beverage	Undisputed	01/23/2026	1111676211	CMS
Amgen Inc.	$15.09	10/08/2024	Food and Beverage	Undisputed	01/23/2026	1117352907	CMS
AstraZeneca Pharmaceuticals LP	$16.45	01/17/2024	Food and Beverage	Undisputed	01/23/2026	1105882048	CMS
AstraZeneca Pharmaceuticals LP	$14.31	05/20/2024	Food and Beverage	Undisputed	01/23/2026	1104647551	CMS
AstraZeneca Pharmaceuticals LP	$14.97	07/17/2024	Food and Beverage	Undisputed	01/23/2026	1105342033	CMS
AstraZeneca Pharmaceuticals LP	$17.47	10/19/2024	Food and Beverage	Undisputed	01/23/2026	1105405545	CMS
Bayer Healthcare Pharmaceuticals Inc.	$9.30	02/06/2024	Food and Beverage	Undisputed	01/23/2026	1086096579	CMS
Bayer Healthcare Pharmaceuticals Inc.	$17.00	03/05/2024	Food and Beverage	Undisputed	01/23/2026	1086154331	CMS
Bayer Healthcare Pharmaceuticals Inc.	$17.58	04/16/2024	Food and Beverage	Undisputed	01/23/2026	1086265679	CMS
Bayer Healthcare Pharmaceuticals Inc.	$19.37	05/21/2024	Food and Beverage	Undisputed	01/23/2026	1086225052	CMS
Bayer Healthcare Pharmaceuticals Inc.	$17.44	06/19/2024	Food and Beverage	Undisputed	01/23/2026	1086192292	CMS
Bayer Healthcare Pharmaceuticals Inc.	$20.92	07/16/2024	Food and Beverage	Undisputed	01/23/2026	1086233975	CMS
Bayer Healthcare Pharmaceuticals Inc.	$19.04	09/17/2024	Food and Beverage	Undisputed	01/23/2026	1086179876	CMS
Bayer Healthcare Pharmaceuticals Inc.	$16.61	10/17/2024	Food and Beverage	Undisputed	01/23/2026	1086251176	CMS
Bayer Healthcare Pharmaceuticals Inc.	$17.60	11/12/2024	Food and Beverage	Undisputed	01/23/2026	1086202808	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$15.48	01/12/2024	Food and Beverage	Undisputed	01/23/2026	1118169324	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$22.47	02/07/2024	Food and Beverage	Undisputed	01/23/2026	1118169328	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$6.18	02/13/2024	Food and Beverage	Undisputed	01/23/2026	1118169312	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$25.09	03/06/2024	Food and Beverage	Undisputed	01/23/2026	1118169330	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$13.31	05/01/2024	Food and Beverage	Undisputed	01/23/2026	1118169322	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$9.70	05/23/2024	Food and Beverage	Undisputed	01/23/2026	1118169316	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$12.51	06/11/2024	Food and Beverage	Undisputed	01/23/2026	1118169318	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$4.92	07/15/2024	Food and Beverage	Undisputed	01/23/2026	1118169310	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$19.52	08/21/2024	Food and Beverage	Undisputed	01/23/2026	1118169326	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$12.51	10/03/2024	Food and Beverage	Undisputed	01/23/2026	1118169320	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$9.69	12/11/2024	Food and Beverage	Undisputed	01/23/2026	1118169314	CMS
Boston Scientific Corporation	$54.69	02/12/2024	Food and Beverage	Undisputed	01/23/2026	1092623376	CMS
Boston Scientific Corporation	$86.95	02/20/2024	Food and Beverage	Undisputed	01/23/2026	1092623378	CMS
Currax Pharmaceuticals LLC	$13.62	12/16/2024	Food and Beverage	Undisputed	01/23/2026	1089509720	CMS
Dexcom, Inc.	$29.72	02/09/2024	Food and Beverage	Undisputed	01/23/2026	1153290689	CMS
Dexcom, Inc.	$26.31	04/12/2024	Food and Beverage	Undisputed	01/23/2026	1153290691	CMS
Dexcom, Inc.	$25.68	06/21/2024	Food and Beverage	Undisputed	01/23/2026	1153290693	CMS
Dexcom, Inc.	$27.55	10/25/2024	Food and Beverage	Undisputed	01/23/2026	1153290695	CMS
Exact Sciences Corporation	$16.65	02/27/2024	Food and Beverage	Undisputed	01/23/2026	1114833895	CMS
Exact Sciences Corporation	$14.59	11/19/2024	Food and Beverage	Undisputed	01/23/2026	1114833901	CMS
GlaxoSmithKline, LLC.	$17.20	05/10/2024	Food and Beverage	Undisputed	01/23/2026	1116576258	CMS
GlaxoSmithKline, LLC.	$22.89	09/23/2024	Food and Beverage	Undisputed	01/23/2026	1115721897	CMS
GlaxoSmithKline, LLC.	$13.33	10/11/2024	Food and Beverage	Undisputed	01/23/2026	1116594182	CMS
GlaxoSmithKline, LLC.	$22.91	12/06/2024	Food and Beverage	Undisputed	01/23/2026	1116495436	CMS
Lilly USA, LLC	$23.12	07/15/2024	Food and Beverage	Undisputed	01/23/2026	1136092894	CMS
Lilly USA, LLC	$20.15	09/02/2024	Food and Beverage	Undisputed	01/23/2026	1136099266	CMS
Lilly USA, LLC	$16.02	10/10/2024	Food and Beverage	Undisputed	01/23/2026	1136090032	CMS
Lilly USA, LLC	$21.13	12/04/2024	Food and Beverage	Undisputed	01/23/2026	1136109000	CMS
Merck Sharp & Dohme LLC	$14.75	10/16/2024	Food and Beverage	Undisputed	01/23/2026	1141689102	CMS
Novo Nordisk Inc	$17.04	01/04/2024	Food and Beverage	Undisputed	01/23/2026	1096759640	CMS
Novo Nordisk Inc	$17.92	01/25/2024	Food and Beverage	Undisputed	01/23/2026	1097214797	CMS
Novo Nordisk Inc	$16.83	02/12/2024	Food and Beverage	Undisputed	01/23/2026	1097437129	CMS
Novo Nordisk Inc	$15.83	03/26/2024	Food and Beverage	Undisputed	01/23/2026	1096896171	CMS
Novo Nordisk Inc	$3.31	04/03/2024	Food and Beverage	Undisputed	01/23/2026	1097241187	CMS
Novo Nordisk Inc	$4.67	04/21/2024	Food and Beverage	Undisputed	01/23/2026	1096616238	CMS
Novo Nordisk Inc	$15.86	04/30/2024	Food and Beverage	Undisputed	01/23/2026	1096680606	CMS
Novo Nordisk Inc	$15.86	05/28/2024	Food and Beverage	Undisputed	01/23/2026	1097406582	CMS
Novo Nordisk Inc	$13.92	06/18/2024	Food and Beverage	Undisputed	01/23/2026	1097615794	CMS
Novo Nordisk Inc	$12.41	07/09/2024	Food and Beverage	Undisputed	01/23/2026	1096907875	CMS
Novo Nordisk Inc	$17.22	08/07/2024	Food and Beverage	Undisputed	01/23/2026	1096646307	CMS
Novo Nordisk Inc	$24.68	09/30/2024	Food and Beverage	Undisputed	01/23/2026	1097663914	CMS
Novo Nordisk Inc	$20.34	10/28/2024	Food and Beverage	Undisputed	01/23/2026	1097815749	CMS
Novo Nordisk Inc	$15.04	11/01/2024	Food and Beverage	Undisputed	01/23/2026	1096899492	CMS
Optinose US, Inc.	$20.02	10/31/2024	Food and Beverage	Undisputed	01/23/2026	1142182708	CMS
PFIZER INC.	$20.28	04/05/2024	Food and Beverage	Undisputed	01/23/2026	1131421109	CMS
PFIZER INC.	$15.80	07/24/2024	Food and Beverage	Undisputed	01/23/2026	1132038336	CMS
PFIZER INC.	$16.33	10/23/2024	Food and Beverage	Undisputed	01/23/2026	1132081196	CMS
PFIZER INC.	$15.19	12/02/2024	Food and Beverage	Undisputed	01/23/2026	1131193238	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$15.03	08/13/2024	Food and Beverage	Undisputed	01/23/2026	1153437842	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$14.25	10/02/2024	Food and Beverage	Undisputed	01/23/2026	1153597333	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$14.12	12/11/2024	Food and Beverage	Undisputed	01/23/2026	1153564329	CMS
Seqirus USA Inc	$19.86	02/21/2024	Food and Beverage	Undisputed	01/23/2026	1125634197	CMS
Sumitomo Pharma America, Inc.	$21.79	05/21/2024	Food and Beverage	Undisputed	01/23/2026	1148903261	CMS
Sumitomo Pharma America, Inc.	$24.95	07/18/2024	Food and Beverage	Undisputed	01/23/2026	1148903263	CMS
Sumitomo Pharma America, Inc.	$15.98	08/28/2024	Food and Beverage	Undisputed	01/23/2026	1148903265	CMS
Sumitomo Pharma America, Inc.	$23.58	10/29/2024	Food and Beverage	Undisputed	01/23/2026	1148903267	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.